Chemotherapy News and Research

Latest Chemotherapy News and Research

Common heartburn medications could decrease effects of chemotherapy in cancer patients

Something as seemingly harmless as a heartburn pill could lead cancer patients to take a turn for the worse.

16 Dec 2016

Study suggests revolutionary way to make cancer cells more susceptible to existing chemotherapies

The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.

16 Dec 2016

Scientists isolate and characterize therapy-resistant dormant leukemia cells

Dr. Irmela Jeremias from Helmholtz Zentrum München and her colleagues have succeeded in finding a small population of inactive leukemia cells that is responsible for relapse of the disease.

15 Dec 2016

Protective effect of ER-beta more pronounced in breast cancer patients who undergo chemotherapy

It is known from previous research that the ER-beta estrogen receptor often has a protective effect. A new study from Lund University in Sweden has found that this effect is more pronounced in patients that undergo chemotherapy.

15 Dec 2016

New technology that increases Natural Killer cells to stop cancers gets licensed

Our bodies contain Natural Killer (NK) cells - an army that stops cancers and viruses before they can make us sick.

15 Dec 2016

Lactate component responsible for anti-tumor effects of plasma medicine, research shows

Physical plasma is one of the four fundamental states of matter, together with solid, liquid, and gas, and can be completely or partially ionized (thermal/hot or non-thermal/cold plasma, respectively).

15 Dec 2016

Phenotypic Personalized Medicine could surmount treatment challenges for acute lymphoblastic leukemia

A team of UCLA bioengineers has demonstrated that its technology may go a long way toward overcoming the challenges of treatment for acute lymphoblastic leukemia, among the most common types of cancer in children, and has the potential to help doctors personalize drug doses.

14 Dec 2016

Novel plasma medicine with anti-tumor effect discovered

Nagoya University researchers develop cold plasma-activated Ringer's solution for chemotherapy. The solution has anti-tumor effects in vitro and in vivo that derive from the lactate component.

14 Dec 2016

UNMC seeking patients with lymphoma to evaluate two-drug oral therapy

The University of Nebraska Medical Center is seeking 24 patients to enroll in a Phase 2a study to evaluate the safety and efficacy of two oral cancer drugs for patients with diffuse large B-cell lymphoma who have relapsed or are resistant to other traditional therapies.

9 Dec 2016

Image-guided percutaneous needle biopsies after NST identify breast cancer patients who achieve pCR

In a pilot study conducted at The University of Texas MD Anderson Cancer Center, image-guided biopsies identified select breast cancer patients who achieved pathologic complete response (pCR) after chemotherapy and/or targeted therapy, neoadjuvant systemic therapy (NST).

9 Dec 2016

New research centre aims to study integration of Traditional Chinese Medicine with western medicine

A NEW research centre to study how Traditional Chinese Medicine (TCM) could be used to treat some of the world’s deadliest diseases is being launched in Beijing today.

9 Dec 2016

Proton Partners acquires Blue Phantom2 data acquisition system to support innovative cancer treatment

The first ever Proton Partners International site, specialising in proton beam therapy, has acquired a Blue Phantom2 data acquisition system from IBA to commission its IBA Proteus ONE compact proton therapy machine and Elekta Versa HD linear accelerator.

9 Dec 2016

Personalized cancer vaccine improves outcomes for patients with AML, clinical study shows

A personalized cancer vaccine markedly improved outcomes for patients suffering from acute myeloid leukemia (AML), a potentially lethal blood cancer, in a clinical trial led by investigators at Beth Israel Deaconess Medical Center.

9 Dec 2016

Study shows experimental treatment not superior to standard therapy for head and neck cancer

Results of the largest Canadian clinical trial to date comparing standard treatment for locally advanced squamous cell head and neck cancer with an experimental treatment, did not show the new treatment is superior.

9 Dec 2016

New model can simplify process of mixing perfect drug cocktails

Drug cocktails, such as those for treating cancer, are best when the proper ingredients are mixed in the right proportions - just like the alcoholic versions offered at the local bar.

9 Dec 2016

Scientists identify biomarkers to predict patient’s response to breast cancer treatment

Why do some breast cancers respond to treatment while others resist it? A study led by researchers at the University of North Carolina Lineberger Comprehensive Cancer Center may provide insight into this important question.

8 Dec 2016

Stem cell-based risk scoring tool could predict AML patient’s response to standard treatment

Leukemia researchers at Princess Margaret Cancer Centre have developed a 17-gene signature derived from leukemia stem cells that can predict at diagnosis if patients with acute myeloid leukemia (AML) will respond to standard treatment.

8 Dec 2016

Researchers developing model to predict breast cancer patient’s response to chemotherapy

University of North Carolina Lineberger Comprehensive Cancer Center researchers and collaborators are working to predict, before treatment, whether an aggressive type of breast cancer will respond to chemotherapy.

8 Dec 2016

Older women with metastatic breast cancer more likely to have genetic alterations in tumors

A University of North Carolina Lineberger Comprehensive Cancer Center-led analysis has found that women who are 65 years or older with metastatic breast cancer were more likely to have a cancer-linked genetic alterations in their tumors, and had a larger total number of genetic alterations, than younger patients overall.

7 Dec 2016

Brain metastasis persists in women with HER2-positive breast cancer despite new targeted therapies

While new targeted treatments developed across the past two decades have led to dramatic survival improvements for women with HER2-positive metastatic breast cancer, University of North Carolina Lineberger Comprehensive Cancer Center researchers and collaborators report that rates of breast cancer brain metastasis for women with this disease have not substantially declined.

7 Dec 2016

Chemotherapy News and Research

Latest Chemotherapy News and Research

Common heartburn medications could decrease effects of chemotherapy in cancer patients

Study suggests revolutionary way to make cancer cells more susceptible to existing chemotherapies

Scientists isolate and characterize therapy-resistant dormant leukemia cells

Protective effect of ER-beta more pronounced in breast cancer patients who undergo chemotherapy

New technology that increases Natural Killer cells to stop cancers gets licensed

Lactate component responsible for anti-tumor effects of plasma medicine, research shows

Phenotypic Personalized Medicine could surmount treatment challenges for acute lymphoblastic leukemia

Novel plasma medicine with anti-tumor effect discovered

UNMC seeking patients with lymphoma to evaluate two-drug oral therapy

Image-guided percutaneous needle biopsies after NST identify breast cancer patients who achieve pCR

New research centre aims to study integration of Traditional Chinese Medicine with western medicine

Proton Partners acquires Blue Phantom2 data acquisition system to support innovative cancer treatment

Personalized cancer vaccine improves outcomes for patients with AML, clinical study shows

Study shows experimental treatment not superior to standard therapy for head and neck cancer

New model can simplify process of mixing perfect drug cocktails

Scientists identify biomarkers to predict patient’s response to breast cancer treatment

Stem cell-based risk scoring tool could predict AML patient’s response to standard treatment

Researchers developing model to predict breast cancer patient’s response to chemotherapy

Older women with metastatic breast cancer more likely to have genetic alterations in tumors

Brain metastasis persists in women with HER2-positive breast cancer despite new targeted therapies

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in